Ads for a Popular Prenatal Genetic Test Leave Out Key Statistics

The company Niptify urges all pregnant women to take a blood test under the slogan 'To avoid unnecessary worry!'. The firm promises to detect especially rare fetal genetic defects 'five times more accurately'. What this wording means in practice is impossible to understand from the advertising materials and the company's website.

This is reported by the Estonian business publication Äripäev in an article for subscribers. Readers will learn two key facts from the article. First, what the 'five times' accuracy promised in Niptify's advertising for detecting rare findings actually means. Second, how CEO Kaarel Krjutškov justified the fact that statistics on incidental findings were left in the shadows in the advertising.

Market context

The publication also provides fresh data on Estonia's private healthcare market. Private clinic sales grew by more than 7% last year. At the same time, according to Sigrid Kõiv, competitive analysis analyst at Äripäev Infopank, the sector's dependence on the Health Insurance Fund remains a serious business risk.

The publication also mentions other stories of the week. The Confido clinic sent a bill to a patient who cancelled her appointment due to illness, which a couple of years later turned into a 560-euro debt and was passed on to debt collectors. Synlab's hematology department is implementing a digitalization project: it increases the volume of patient samples processed and makes it possible to deliver results on the same working day. On the Password program, Logotrade CEO Anti Saluneem told how artificial intelligence is changing the process of ordering corporate gifts.

The demographic debate

The 'Äripäev eetris' program also discussed the demographic agenda. The participants agreed that monotonous propaganda on fertility issues harms the conversation about children and family. In their view, the approach could resemble long-term pension planning — calm and pragmatic.